People: Illumina Inc (ILMN.O)

ILMN.O on Nasdaq

163.92USD
30 Sep 2014
Price Change (% chg)

$-1.30 (-0.79%)
Prev Close
$165.22
Open
$164.97
Day's High
$165.52
Day's Low
$162.78
Volume
869,565
Avg. Vol
1,128,154
52-wk High
$185.00
52-wk Low
$72.77

Search Stocks

Klausner, Richard 

Brief Biography

Dr. Richard D. Klausner, M.D. is Senior Vice President, Chief Medical Officer of Illumina, Inc. Prior to joining Illumina, Dr. Klausner was managing partner of the venture capital firm, The Column Group. Previously, he held roles as Executive Director for Global Health at the Bill and Melinda Gates Foundation and as the eleventh director of the National Cancer Institute between 1995 and 2001. He has served as chief of the cell biology and metabolism branch of the National Institute of Child Health and Human Development, as well as a past president of the American Society of Clinical Investigation. He also has been Chairman of the National Science Education Standards Projects of the National Academy of Sciences. Dr. Klausner is well known for his work in cell and molecular biology, and is the author of more than 300 scientific articles and several books, in addition to receiving numerous awards and honors. He has served as an Advisor to the Presidents of the Academies for counter-terrorism, as a Liaison to the White House Office of Science & Technology Policy, and as a Chief Strategy Advisor for USAID. He currently chairs the International Advisory Board for Samsung, is the Chairman of Audax Health, and previously chaired the Strategic Oversight Council of Sanofi. He is a member of the National Academy of Sciences, the Institute of Medicine, and the American Academy of Arts and Sciences. Dr. Klausner holds an M.D. from Duke Medical School.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

William Rastetter

--

Francis deSouza

6,727,490

Jay Flatley

7,296,270

Marc Stapley

2,220,800

David Walt

--

Mostafa Ronaghi

2,079,570
As Of 28 Dec 2013
Search Stocks